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Introduction
Congenital fibrosis of the extraocular muscle (CFEOM)
syndromes are hereditary eye movement disorders charac-
terized by restrictive paralytic ophthalmoparesis with or
without ptosis [1]. Typically, pupillary function, anterior
segment examination, and fundus oculi are normal.
CFEOM type 1 (MIM 608283) is an autosomal dominant
disorder, which maps to chromosome 12q12 and presents
the classical paralytic ophthalmoparesis phenotype [2]. Neu-
ropathology has revealed absence of the superior division of
the oculomotor nerve and its corresponding α-motoneurons
in the midbrain, associated with dysplasia of the levator
palpebrae superioris and the superior rectus muscles [1, 3].
Most CFEOM1 individuals harbor heterozygous mutations
in the developmental kinesin gene, KIF21A [4].
CFEOM2 (MIM 602753) is an autosomal recessive form
of the disease, clinically consisting of exotropic ophthalmopa-
resis and ptosis, and mapping to chromosome 11q13 in Saudi
Arabian and Turkish families [5]. A further variant
(CFEOM3) is multifaceted and can be associated with dom-
inant mutations in TUBB3 (CFEOM3A, MIM 600638) if
combines ptosis and restrictive external ophthalmoparesis [6,
7]. Bilateral or unilateral manifestations are possible, and
penetrance can be incomplete. Individuals may be able to
raise the eyes above midline or may not have blepharoptosis
[8]. Instead, CFEOM3B (MIM 135700) was reported in a
Turkish family carrying a mutation in KIF21A, and it is
clinically different from CFEOM1 because the absence of
ptosis, unilateral ophthalmoparesis, non-infraducted primary
eye position, or the ability to raise at least one globe above the
horizontal midline were all observed in at least one family
member [4, 9]. Finally, CFEOM3C (MIM 609384) was de-
scribed in a single patient carrying a balanced/unbalanced
reciprocal translocation t(2;13)(q37.3;q12.11) who presented
CFEOM in association with mental retardation and facial
dysmorphism [10].
Additional extraocular signs can occasionally occur in
CFEOM, such as in the Tukel syndrome, a rare disorder in
which ophthalmoparesis and ptosis are accompanied by
oligodactyly–syndactyly of the hands [11]. Cerebellar in-
volvement has been observed in patients having mutations
in TUBB3, though in the context of a more severe and
widespread abnormal cortical neurodevelopment disorder
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[12]. Herein, we describe two patients from CFEOM1 kin-
dred who showed cerebellar atrophy on neuroimaging and,
in adulthood, developed a slowly progressive ataxia, affect-
ing gait and balance.
Patients and Methods
The family (Fig. 1) has already been described elsewhere. It
is the CZ pedigree in [2] in association with the heterozy-
gous p.R954W mutation in KIF21A in several individuals
with nearly full penetrance [2].
The proband (I-1) is a 79-year-old man who presented,
on clinical examination, severe congenital bilateral ptosis
and ophthalmoparesis characterized by inability to raise his
eyes above the horizontal midline and very limited lateral
eye movements. He had undergone surgery in adulthood. In
his 50s, he started experiencing balance problems. No seg-
mental ataxia was evident, but the patient’s gait was broad-
based and tandem walking was impossible. In addition, the
patient was severely dysarthric. The MRI examination
revealed a marked cerebellar atrophy, both in the cerebellar
hemispheres and in the vermis, a homogeneous signal in-
tensity of the cerebral parenchyma, any focal abnormalities,
in either the gray or white matter. The cortex was of normal
thickness and had regular sulcation. The ventricular system
showed a moderate increased size, symmetrical at the mid-
line. The sub-arachnoid spaces were regular, in agreement
with patient’s age. On the whole, the MRI examination
presents subtentorial atrophy (Figs. 2a and 3).
Patient II-1 is a 53-year-old womanwho has developed gait
difficulties in the past 2 years. On neurological examination,
she showed significant ptosis and ophthalmoparesis, involv-
ing up and downgaze mainly, but also horizontal eye
movements to a lesser extent. She showed mild difficulty with
tandem gait. HerMRI examination showed slight enlargement
of the fourth ventricle and of the cerebellar sub-arachnoid
spaces, prominent posterior fossa sub-arachnoid cisterns, sug-
gesting an initial cerebellar atrophy (Fig. 2b).
Her 50-year-old brother (II-3) also started presenting
moderate gait abnormalities over the last few years but
refused further neuroimaging examination. Patient III-4 is
a 33-year-old woman affected by congenital bilateral ptosis
and ophthalmoparesis. Her neurological examination and
brain neuroimaging findings were normal (Fig. 2c).
Discussion
Congenital bilateral ptosis and non-progressive restrictive
ophthalmoparesis are the pivotal signs of CFEOM, which
can be inherited as an autosomal dominant (CFEOM1 and
CFEOM3) [2, 4, 6] or autosomal recessive (CFEOM2) [5]
trait. In addition to bilateral ptosis and restrictive external
ophthalmoparesis with the eyes partially or completely fixed
in infraducted and strabismic position, extraocular signs are
also possible, including oligodactyly–syndactyly of the hands
[11], mental retardation and facial dysmorphism [10], and
Marcus Gunn jaw winking phenomenon and epilepsy [13].
Patients with the latter variant can also show neuroradiologi-
cal abnormalities, such as agenesis of the corpus callosum,
colpocephaly, and enlarged ventricles, or widespread cortical
dysplasia and caudate hypoplasia [14]. To date, however, no
patient with genetically confirmed CFEOM1 has manifested
clinical symptoms of cerebellar atrophy. In a study by Yoshida
and co-workers [15], direct gene testing failed to detect alter-
ations in KIF21A in several members of a Japanese pedigree
with syndromic CFEOM. Interestingly, cerebellar hypoplasia,
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Fig. 1 A family with
congenital fibrosis of the
extraocular muscles type 1
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more prominent in the vermis than in the hemispheres, was
seen in all the family members, although only middle-aged
subjects showed signs of gait ataxia, which had appeared in
adolescence. However, the disorder appeared to exhibit in-
complete penetrance since two younger family members with
CFEOM showed no clinical signs of cerebellar involvement.
We observed cerebellar vermis atrophy and late-onset
cerebellar syndrome in two patients harboring the p.R954W
mutation in KIF21A. No signs or symptoms other than
CFEOM were seen in patient III-4, the 33-year-old daughter
of case II-1, who also had an unremarkable brain MRI.
Most patients with CFEOM1, and rare cases of CFEOM3,
harbor mutations in the kinesin gene KIF21A, whose exact
function is unknown [2]. Kinesins transfer cargo along
microtubules and are responsible for anterograde axonal
transport in neurons. In mammalian cells, kinesins are tetra-
meric proteins containing two heavy (alpha) chains, which
provide the tubulin binding site and the ATPase domains,
and two light (beta) chains, which are responsible for kinesin
specificity for organelle binding [16]. It has been suggested
that KIF21A mutations could interfere with protein dimer-
ization [17]. During embryonic life, this impairment could
lead to deficient cargo transport from the oculomotor moto-
neurons to the developing neuromuscular junction of the
extraocular muscle, resulting in hypotrophy of these muscles
at birth. It is tempting to hypothesize that failure of kinesin-
dependent neuronal transport could also be responsible for
the anatomical malformation of the cerebellum observed in
some subjects. Consistent with this idea is the recent finding
that kinesin light-chain KLC3 [18] is highly expressed in the
adult cerebellum. Accordingly, a marked decrease in the
density of synaptic vesicles and in the amount of synaptic
terminals, as well as a focal neuronal loss in several brain
areas of KIF1A motor protein-deficient mice, has been ob-
served. Moreover, the premature neuronal death matches
chronologically with the beginning of production of KIF1A
in wild-type cells, this supporting the hypothesis that the
reduction of kinesin transport in mutated neurons may be
crucial for keeping cellular trophism [19].
Since we observed a cerebellar syndrome and subtentorial
hypotrophy only in the two older patients with CFEOM1, but
not in a younger relative, we cannot exclude that impaired
cargo transport could cause gradual cerebellar atrophy, mainly
of the vermis, with aging. Establishing the exact time frame of
this mechanism in CFEOM1, however, is a difficult task that
will require clinical and radiological follow-up.
Fig. 2 MRI T1-weighted brain sagittal scans showing three patients
(a–c) affected by congenital fibrosis of the extraocular muscles type 1.
a (patient I-1 in the pedigree): marked atrophy of the cerebellum, both
in the cerebellar hemispheres and in the vermis. b (patient II-1):
enlargement of the fourth ventricle and cerebellar sub-arachnoid
spaces, prominent posterior fossa sub-arachnoid cisterns, indicating
initial cerebellar atrophy. c (patient III-4): normal morphology, size,
and signal intensity of the cerebellum
Fig. 3 Axial brain MRI in a 79-year-old patient with congenital
fibrosis of extraocular muscles (I-1 in the pedigree). T1 (A1) and T2-
weighted (A2) scans at the level of fourth ventricle. T1 (A3) and T2-
weighted (A4) images at the level of corona radiata
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Summary
We described a family with a molecularly confirmed form of
CFEOM1 and a late-onset cerebellar syndrome. Brain MRI
showed vermis atrophy in two older family members, who
also manifested gait impairment, whereas both neurological
examination and neuroimaging findings were normal in a
younger relative who harbored the same mutation.
Although clinical and radiological follow-up of patients are
needed to confirm the existence of a close link between a
kinesin motor protein and the development of cerebellar atro-
phy, we propose to investigate KIF21A in autosomal domi-
nant, late-onset, ataxic syndromes with progressive
oculomotor impairment and ptosis. Conversely, signs of cer-
ebellar involvement should be assessed in adult CFEOM1
patients.
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